The combination of selinexor plus ruxolitinib met the first co-primary endpoint demonstrating a statistically significant improvement of spleen volume reduction (SVR35) of 49.8% for the combination arm vs 28%...
FLORENCE, Italy and NEW YORK, June 14, 2026 (GLOBE NEWSWIRE) -- The Menarini Group (“Menarini”), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. (“Stemline”), a wholly-owned subsidiary of the Menarini Group focused on bringing transformational oncology treatments to cancer patients, announced that new data related to the pivotal Phase 3 SENTRY trial will be presented as a late-breaking oral at The European Hematology Association (EHA) 2026 Congress.
Cognition AI, an artificial intelligence start-up specializing in software coding assistance, strategically acquired rival Windsurf, furthering the competitive landscape in AI technology. This acquisition...
Zohran Mamdani, the democratic socialist extraordinaire, apparently thinks hobnobbing with New York’s corporate elite is a productive pastime. Fresh off his primary win, he’s...
A vessel, the Monna Lisa, engineered in Romania at an investment of approximately €250 million, is strategically positioned for deployment in global electric power...
Elon Musk's AI venture, xAI, encountered a significant issue where a code update led Grok, its chatbot, to disseminate antisemitic messages. This incident underscores...
Ah, the eternal dance of geopolitical chess, where tariffs become the favorite weapon of choice for those claiming to defend the sanctity of national...
Ah, Trump strikes again, wielding tariffs like a toddler with a crayon—bold, unpredictable, and liable to stain everything. This latest escapade involves a 50%...
Nearly 100,000 car buyers of the 2025 model-year were surveyed about their shiny new vehicles. Unsurprisingly, Audi found itself at the bottom with 269...